Modeling asthma exacerbations through lung function in children

Journal of Allergy and Clinical Immunology

Volumn 130, Issue 5, 2012, Pages 1065-1070

  Wu, Ann Chen ^a,b   Gregory, Martin ^c   Kymes, Steven ^c   Lambert, Dennis ^c   Edler, Joshua ^c   Stwalley, Dustin ^c   Fuhlbrigge, Anne L ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Asthma; emergency department visits; FEV1 predicted; hospitalizations; lung function; model; pediatric patients

Indexed keywords

CORTICOSTEROID;

ARTICLE; ASTHMA; BINOMIAL DISTRIBUTION; CHILD; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; EMERGENCY WARD; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INDEPENDENT VARIABLE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROBABILITY; SCHOOL CHILD; SPIROMETRY;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ASTHMA; CHILD; COMPUTER SIMULATION; DECISION SUPPORT TECHNIQUES; DISEASE PROGRESSION; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; LUNG; MALE; MODELS, BIOLOGICAL; MULTICENTER STUDIES AS TOPIC; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY FUNCTION TESTS; UNITED STATES;

EID: 84869143758     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.08.009     Document Type: Article

References (35)

1. Centers for Disease Control and Prevention (CDC). Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001-2009 MMWR Morb Mortal Wkly Rep 60 2011 547 552
2. National Asthma Education and Prevention Program Expert Panel Report: guidelines for the diagnosis and management of asthma update on selected topics-2002 J Allergy Clin Immunol 110 2002 S141 S219
3. L.J. Akinbami, J.E. Moorman, and X. Liu Asthma prevalence, health care use, and mortality: United States, 2005-2009 Natl Health Stat Rep 2011 1 14
4. S.B. Barnett, and T.A. Nurmagambetov Costs of asthma in the United States: 2002-2007 J Allergy Clin Immunol 127 2011 145 152
5. M.J. Sculpher, and M. Price Measuring costs and consequences in economic evaluation in asthma Respir Med 97 2003 508 520 (Pubitemid 36519522)
6. A.D. Paltiel, A.L. Fuhlbrigge, B.T. Kitch, B. Liljas, S.T. Weiss, and P.J. Neumann Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model J Allergy Clin Immunol 108 2001 39 46 (Pubitemid 32662230)
7. A.L. Fuhlbrigge, B.T. Kitch, A.D. Paltiel, K.M. Kuntz, P.J. Neumann, and D.W. Dockery FEV(1) is associated with risk of asthma attacks in a pediatric population J Allergy Clin Immunol 107 2001 61 67 (Pubitemid 32105245)
8. K.M. Kuntz, B.T. Kitch, A.L. Fuhlbrigge, A.D. Paltiel, and S.T. Weiss A novel approach to defining the relationship between lung function and symptom status in asthma J Clin Epidemiol 55 2002 11 18 (Pubitemid 34037033)
9. P.L. Enright, L.R. Johnson, J.E. Connett, H. Voelker, and A.S. Buist Spirometry in the Lung Health Study, 1: methods and quality control Am Rev Respir Dis 143 1991 1215 1223
10. P.L. Enright, M.D. Lebowitz, and D.W. Cockroft Physiologic measures: pulmonary function tests. Asthma outcome Am J Respir Crit Care Med 149 1994 S9 18 discussion S9-20
11. L.A. Prosser, A.A. Stinnett, P.A. Goldman, L.W. Williams, M.G. Hunink, and L. Goldman Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics Ann Intern Med 132 2000 769 779 (Pubitemid 30317791)
12. A.N. Tosteson, D.I. Rosenthal, L.J. Melton III, and M.C. Weinstein Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy Ann Intern Med 113 1990 594 603 (Pubitemid 20346189)
13. K.A. Freedberg, J.A. Scharfstein, G.R. Seage III, E. Losina, M.C. Weinstein, and D.E. Craven The cost-effectiveness of preventing AIDS-related opportunistic infections JAMA 279 1998 130 136
14. A.L. Fuhlbrigge, S.J. Bae, S.T. Weiss, K.M. Kuntz, and A.D. Paltiel Cost-effectiveness of inhaled steroids in asthma: impact of effect on bone mineral density J Allergy Clin Immunol 117 2006 359 366 (Pubitemid 43192021)
15. A.C. Wu, A.D. Paltiel, K.M. Kuntz, S.T. Weiss, and A.L. Fuhlbrigge Cost-effectiveness of omalizumab in adults with severe asthma: results from the Asthma Policy Model J Allergy Clin Immunol 120 2007 1146 1152 (Pubitemid 350029901)
16. Childhood Asthma Management Program Research Group The Childhood Asthma Management Program (CAMP): design, rationale, and methods Control Clin Trials 20 1999 91 120
17. E.F. Halpern, M.C. Weinstein, M.G. Hunink, and G.S. Gazelle Representing both first- and second-order uncertainties by Monte Carlo simulation for groups of patients Med Decis Making 20 2000 314 322 (Pubitemid 30470727)
18. D.B. Coultas, C.A. Howard, B.J. Skipper, and J.M. Samet Spirometric prediction equations for Hispanic children and adults in New Mexico Am Rev Respir Dis 138 1988 1386 1392 (Pubitemid 19005421)
19. R.J. Knudson, M.D. Lebowitz, C.J. Holberg, and B. Burrows Changes in the normal maximal expiratory flow-volume curve with growth and aging Am Rev Respir Dis 127 1983 725 734 (Pubitemid 13101554)
20. M.C. Weinstein Recent developments in decision-analytic modelling for economic evaluation Pharmacoeconomics 24 2006 1043 1053 (Pubitemid 44683362)
21. A.L. Fuhlbrigge, S.T. Weiss, K.M. Kuntz, and A.D. Paltiel Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma Pediatrics 118 2006 e347 e355
22. J.S. Mandelblatt, K.R. Yabroff, and J.F. Kerner Equitable access to cancer services: a review of barriers to quality care Cancer 86 1999 2378 2390 (Pubitemid 30010381)
23. J. Corren, A.G. Harris, D. Aaronson, W. Beaucher, R. Berkowitz, and E. Bronsky Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma J Allergy Clin Immunol 100 1997 781 788 (Pubitemid 28298997)
24. M. Noonan, P. Chervinsky, W.W. Busse, S.C. Weisberg, J. Pinnas, and B.P. de Boisblanc Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life Am J Respir Crit Care Med 152 1995 1467 1473
25. L.J. Okamoto, M. Noonan, B.P. DeBoisblanc, and D.J. Kellerman Fluticasone propionate improves quality of life in patients with asthma requiring oral corticosteroids Ann Allergy Asthma Immunol 76 1996 455 461 (Pubitemid 26153158)
26. L. Agertoft, and S. Pedersen Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children Respir Med 88 1994 373 381 (Pubitemid 24167107)
27. B. Dzyngel, S. Kesten, and K.R. Chapman Assessment of an ambulatory care asthma program J Asthma 31 1994 291 300 (Pubitemid 24275336)
28. J. Tamaoki, M. Kondo, N. Sakai, J. Nakata, H. Takemura, and A. Nagai Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group Am J Respir Crit Care Med 155 1997 1235 1240 (Pubitemid 27172764)
29. M. Lara, N. Duan, C. Sherbourne, N. Halfon, A. Leibowitz, and R.H. Brook Children's use of emergency departments for asthma: persistent barriers or acute need? J Asthma 40 2003 289 299 (Pubitemid 36676409)
30. D. Li, D. German, S. Lulla, R.G. Thomas, and S.R. Wilson Prospective study of hospitalization for asthma: a preliminary risk factor model Am J Respir Crit Care Med 151 1995 647 655
31. H.J. Farber Risk of readmission to hospital for pediatric asthma J Asthma 35 1998 95 99 (Pubitemid 28135001)
32. L.B. Bacharier, C. Dawson, G.R. Bloomberg, B. Bender, L. Wilson, and R.C. Strunk Hospitalization for asthma: atopic, pulmonary function, and psychological correlates among participants in the Childhood Asthma Management Program Pediatrics 112 2003 e85 e92
33. J. Wever-Hess, J.M. Kouwenberg, E.J. Duiverman, J. Hermans, and A.M. Wever Risk factors for exacerbations and hospital admissions in asthma of early childhood Pediatr Pulmonol 29 2000 250 256 (Pubitemid 30176636)
34. R.C. Strunk, A.L. Sternberg, L.B. Bacharier, and S.J. Szefler Nocturnal awakening caused by asthma in children with mild-to-moderate asthma in the Childhood Asthma Management Program J Allergy Clin Immunol 110 2002 395 403
35. T.A. Lieu, A.M. Capra, C.P. Quesenberry, G.R. Mendoza, and M. Mazar Computer-based models to identify high-risk adults with asthma: is the glass half empty or half full? J Asthma 36 1999 359 370 (Pubitemid 29318976)